Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Revenue

Vectorite Biomedical had revenue of 33.73M TWD in the half year ending June 30, 2025, with 29.81% growth. This brings the company's revenue in the last twelve months to 67.90M, up 26.97% year-over-year. In the year 2024, Vectorite Biomedical had annual revenue of 57.77M with 3.43% growth.

• Revenue (ttm): 67.90M
• Revenue Growth: +26.97%
• P/S Ratio: 8.99
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 610.61M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.77M	1.92M	3.43%
Dec 31, 2023	55.85M	12.94M	30.15%
Dec 31, 2022	42.91M	14.14M	49.16%
Dec 31, 2021	28.77M	4.23M	17.22%
Dec 31, 2020	24.54M	-2.00M	-7.52%